Adaptive Immune Regulation of Traumatic Injury
Adaptive Immune Regulation of Traumatic Injury
批准号:
10186694
负责人:
JAMES A. LEDERER
金额:
$41.46万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
未结题
起止时间:
2020-06-10 至 2025-05-31
关键词:
AcuteAddressAffectAntigensApplied ResearchBacteriaBacterial PneumoniaBasic ScienceBehaviorBiologyBurn TraumaCD4 Positive T LymphocytesCD8-Positive T-LymphocytesCellsChronicClinicalComplexCritical IllnessDataDiseaseEquilibriumGoalsHealthHomeostasisImmuneImmune responseImmune systemImmunityImmunologyImmunotherapyInfectionInflammationInflammatoryInjuryKnowledgeLifeModelingMolecularMolecular ProfilingMusNatureOpportunistic InfectionsOrganOutcomeOutcomes ResearchPatientsPatternPeripheralPhenotypeProcessPublishingRegulatory T-LymphocyteReportingResearchSeriesSpecificityStimulusSystemic Inflammatory Response SyndromeT-Cell ReceptorT-LymphocyteTestingTherapeuticTissuesTraumaTraumatic injuryantimicrobialbasecell typecytokineexperimental studyimmune functionimmunoreactionimmunoregulationimprovedinjuredinsightinterestnovelpost-traumaresponserestorationsevere injurytissue injury
中文摘要
项目总结
创伤会破坏免疫系统的动态平衡,这会使患者容易患上机会主义。
感染和其他创伤相关并发症,如全身炎症反应综合征(SIRS),
器官损伤和慢性危重疾病。创伤诱导独特而复杂的宿主反应
由组织损伤和与危险相关的分子模式(DAMP)的释放引发
特定的免疫反应。我们发现了一种称为调节性T细胞(Tregs)的CD4+T细胞亚群
在小鼠烧伤创伤模型中被损伤急性激活。丹参的抗炎抑制活性
Tregs因创伤而增强,这表明Tregs可能控制创伤后炎症的强度
和恢复免疫系统的动态平衡。人的组织中可能含有不同数量的Tregs或
对创伤有不同的功能Treg反应,这可能决定他们对创伤的反应轨迹
创伤性损伤。我们的假设是,树突状细胞控制对湿气的免疫反应,并影响
宿主对创伤的反应轨迹。为了解决这一假设,我们提出了一系列创伤
系统询问的免疫学研究:1)免疫系统表型的Treg调控和
动态平衡;2)创伤诱导的Treg激活机制;3)调节Treg对免疫的影响
表型、抗微生物免疫功能和两次SIRS反应。这个项目的具体目标是
1)确定CD4+Tregs如何控制免疫系统对创伤的反应性;2)确定其特异性
以及创伤反应性CD4+Tregs和其他T细胞的分子性质,3)研究CD4+Tregs如何
影响抗微生物免疫和两次SIRS。我们预计,这项研究的结果将
显著提高我们对调节创伤的特定免疫机制的基础知识
豁免权。我们有几个重要的目标,我们希望在这个项目的过程中实现;1)
对Treg激活和功能的生物学提供新的见解,2)加深对
免疫系统对哺乳动物创伤反应的调控,以及3)探索其治疗潜力
调节Treg的激活和功能作为一种特异性创伤免疫疗法来改善免疫功能和
创伤后的平衡。
英文摘要
PROJECT SUMMARY
Traumatic injuries disrupt immune system homeostasis, which can predispose patients to opportunistic
infections and other trauma-associated complications like systemic inflammatory response syndrome (SIRS),
organ damage, and chronic critical illnesses. Trauma induces unique and complex host responses that are
initiated by tissue damage and the release of danger-associated molecular patterns (DAMPs) that trigger
specific immune reactions. We identified that a subset of CD4+ T cells called regulatory T cells (Tregs) are
acutely activated by injury in a mouse burn trauma model. The counter-inflammatory suppressive activity of
Tregs is enhanced by trauma, which suggests that Tregs may control the intensity of post-trauma inflammation
and restoration of immune system homeostasis. People can have different numbers of Tregs in their tissues or
have different functional Treg responses to trauma that could determine trajectory of their response to
traumatic injuries. Our hypothesis is that Tregs control immune reactions to DAMPs and influence the
trajectory of the host response to trauma. To address this hypothesis, we propose a series of trauma
immunology studies to systematically interrogate; 1) Treg control of immune system phenotypes and
homeostasis, 2) trauma-induced Treg activation mechanisms, and 3) effects of modulating Tregs on immune
phenotypes, anti-microbial immune function, and the two-hit SIRS response. The specific aims for this project
are; 1) To determine how CD4+ Tregs control immune system reactivity to trauma, 2) To define the specificity
and molecular nature of trauma-reactive CD4+ Tregs and other T cells, 3) To investigate how CD4+ Tregs
influence anti-microbial immunity and two-hit SIRS. We anticipate that the outcome of this research will
significantly advance our fundamental knowledge of specific immune mechanisms that modulate trauma
immunity. We have several significant goals that we wish to achieve during the course of this project; 1) to
provide new insights into the biology of Treg activation and function, 2) to develop a deeper understanding of
immune system control of the mammalian trauma response, and 3) to explore the therapeutic potential of
modulating Treg activation and function as a specific trauma immunotherapy to improve immune function and
balance following trauma.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeting Trained Immunity in Trauma-Induced Immune Dysregulation
-
批准号:10714384
-
项目类别:
-
资助金额:$51.05万
-
财政年份:2023
-
负责人:JAMES A. LEDERER
-
依托单位:
Adaptive Immune Regulation of Traumatic Injury
-
批准号:10415072
-
项目类别:
-
资助金额:$41.46万
-
财政年份:2020
-
负责人:JAMES A. LEDERER
-
依托单位:
Adaptive Immune Regulation of Traumatic Injury
-
批准号:10624318
-
项目类别:
-
资助金额:$41.46万
-
财政年份:2020
-
负责人:JAMES A. LEDERER
-
依托单位:
Therapy of acute radiation syndrome and its complications by mesenchymal stromal cells conditioned with Toll-like receptor 9 agonists
-
批准号:9899920
-
项目类别:
-
资助金额:$58.23万
-
财政年份:2018
-
负责人:JAMES A. LEDERER
-
依托单位:
Therapy of acute radiation syndrome and its complications by mesenchymal stromal cells conditioned with Toll-like receptor 9 agonists
-
批准号:10374106
-
项目类别:
-
资助金额:$58.23万
-
财政年份:2018
-
负责人:JAMES A. LEDERER
-
依托单位:
Cellular Systems Core
-
批准号:10454989
-
项目类别:
-
资助金额:$26.71万
-
财政年份:2016
-
负责人:JAMES A. LEDERER
-
依托单位:
Cellular Systems Core
-
批准号:10281359
-
项目类别:
-
资助金额:$28.69万
-
财政年份:2016
-
负责人:JAMES A. LEDERER
-
依托单位:
Single Cell and Immunoanalysis Core
-
批准号:10455094
-
项目类别:
-
资助金额:$14.11万
-
财政年份:2016
-
负责人:JAMES A. LEDERER
-
依托单位:
Single Cell and Immunoanalysis Core
-
批准号:10615219
-
项目类别:
-
资助金额:$14.11万
-
财政年份:2016
-
负责人:JAMES A. LEDERER
-
依托单位:
Cellular Systems Core
-
批准号:10684886
-
项目类别:
-
资助金额:$26.71万
-
财政年份:2016
-
负责人:JAMES A. LEDERER
-
依托单位:
Restoring Immune Function Following Radiation Injuries by TLR9 Agonist Treatment
-
批准号:8660290
-
项目类别:
-
资助金额:$65.95万
-
财政年份:2013
-
负责人:JAMES A. LEDERER
-
依托单位:
Restoring Immune Function Following Radiation Injuries by TLR9 Agonist Treatment
-
批准号:8573161
-
项目类别:
-
资助金额:$58.43万
-
财政年份:2013
-
负责人:JAMES A. LEDERER
-
依托单位:
Injury-Specific Activation of the Immune System
-
批准号:8115690
-
项目类别:
-
资助金额:$41.45万
-
财政年份:2011
-
负责人:JAMES A. LEDERER
-
依托单位:
Injury-Specific Activation of the Immune System
-
批准号:8665375
-
项目类别:
-
资助金额:$41.48万
-
财政年份:2011
-
负责人:JAMES A. LEDERER
-
依托单位:
Injury-Specific Activation of the Immune System
-
批准号:8281415
-
项目类别:
-
资助金额:$41.48万
-
财政年份:2011
-
负责人:JAMES A. LEDERER
-
依托单位:
Injury-Specific Activation of the Immune System
-
批准号:8468920
-
项目类别:
-
资助金额:$39.0万
-
财政年份:2011
-
负责人:JAMES A. LEDERER
-
依托单位:
Immunological Complications of Radiation Combined Injury
-
批准号:7898011
-
项目类别:
-
资助金额:$9.97万
-
财政年份:2009
-
负责人:JAMES A. LEDERER
-
依托单位:
Immunological Complications of Radiation Combined Injury
-
批准号:8127884
-
项目类别:
-
资助金额:$59.54万
-
财政年份:2008
-
负责人:JAMES A. LEDERER
-
依托单位:
Immunological Complications of Radiation Combined Injury
-
批准号:7560141
-
项目类别:
-
资助金额:$25.06万
-
财政年份:2008
-
负责人:JAMES A. LEDERER
-
依托单位:
Immunological Complications of Radiation Combined Injury
-
批准号:7649465
-
项目类别:
-
资助金额:$16.87万
-
财政年份:2008
-
负责人:JAMES A. LEDERER
-
依托单位:
海外基金